Summary.-Attempts were made to induce immunity to 5 spontaneous rat sarcomas transplanted into syngeneic recipients. Rats were immunized by surgical removal of growing tumour transplants or by treatment with attenuated tumour, followed by challenge with tumour cells in suspension. Two tumours were apparently not immunogenic, but a low level of immunity was induced against 2, and weak evidence of immunity was observed with another. Induced immunity was individually specific rather than cross-reactive. It is concluded that, contrary to some reports, some spontaneous animal tumours are immunogenic in the strain of origin.
drawn to the merits or otherwise of spontaneous animal tumours compared with artificially induced ttumours in experimental cancer research, particularly in the study of tumour immunology (Hewitt et al., 1976; Martin et al., 1977; Klein & Klein, 1977) . It is widely accepted that most virus-induced tumours and many chemically induced tumours have specific antigens capable of inducing a tumour rejection response in suitably immtunized inbred animals (Klein & Klein, 1977; Embleton & Baldwin, 1980) . Truly spontaneous tumours, on the other hand, tend to be deficient in this property, and this has led to criticism of the use of experimentally induced tumour models, on the grounds that they do not represent a natural situation (Hewitt et al., 1976 : Hewitt, 1978 .
Discounting tumours arising within high-tumour-incidence animal strains or those with a known viral aetiology, there is a sparse literature on the immunology of spontaneous animal tumours, possibly owing to their infrequent occurrence in normal laboratory animal populations. The earliest report was that of Prehn & Main (1957) , in which it, was clearly shown that mice immmunized against syngeneic 3-methylcholanthrene-induced sarcomas by amputation of a tumour-bearing limb were resistant to grafts of the same tumour, but mice similarly immunized against spontaneously arising sarcomas were not immune to rechallenge. It is possible that the challenge graft overcame any weak responses to the spontaneous tumours, and Hammond et al. (1967) demonstrated weak immunity against spontaneous murine fibrosarcomas and myoepitheliomas, using a similar method of immunization but low numbers of dispersed cells as challenge inocula. Hewitt, et al. (1976) published results of a longterm study in which 27 spontaneous murine tumours of various types were evaluated for their transplantation characteristics in experimental circumstances where tumour-immune responses might, be detected, though many of the experiments were not originally designed for this purpose. No clear evidence for tumourimmune responses was obtained, and it was concluded that these tumours lacked antigens capable of evoking transplantation immunity in syngeneic hosts.
Spontaneous tumours of other laboratory animals conform to a similar pattern. Thus Baldwin (1.966) was able to demonstrate significant immunity to a spon-taneous rat squamous-cell carcinoma, but was unable to detect any response to a reticulum-cell sarcoma in immunized rats. Baldwin & Embleton (1969) examined 9 spontaneous rat mammary carcinomas, and found one of these to be fairly strongly immunogenic, 2 only weakly immunogenic and the other 6 apparently nonimmunogenic in syngeneic rats. A spontaneous rat leukaemia (Wrathmell & Alexander, 1976) and spontaneous hamster lymphomas (Vasa-Thomas et al., 1977) have been reported to be weakly immunogenic in the inbred strain of origin.
Thus the literature suggests that some spontaneous tumours have tumour-associated antigens capable of inducing immunity to challenge, though these may be in the minority. Our work over the past few years reinforces this view, and the present paper reports the demonstration of immunogenicity of a small number of spontaneous rat sarcomas.
MATERIALS AND METHODS
Animals.-Inbred WAB/Not rats were used. They have been bred, from an originally inbred colony, by continuous brother-sister mating for 50 generations. These rats accept skin grafts between individuals of the same sex.
Tumours.-Five primary sarcomas (Sp7. Sp20, Sp24, Sp25 and Sp4l) arose without deliberate induction in male breeding rats. They all arose before June 1976 and were transplanted s.c. into syngeneic male rats and maintained as serially propogated lines. In addition, transplant lines were established from 2 lymph-node metastases of Sp25, designated Sp26 and Sp27 respectively. Samples of all tumours at various generations of transplantation were stored in liquid N2. They were transplanted back into syngeneic male rats as required, after rapid thawing at 370C.
Immunization.-Syngeneic male rats were immunized against transplanted tumours using one of the following techniques:
(a) Tumour fragments were transplanted (Baldwin, 1966) . The challenge inocula were given s.c. in most cases, but in some experiments they were given by other routes (i.p., i.m. or i.v.) as indicated in the text.
Growth of tumour inocula was monitored weekly. Tumours growing s.c. were measured with calipers in 2 perpendicular planes to provide an indication of growth rate. At the end of experiments involving i.v. challenge inocula, the lungs were removed for estimation of surface tumour nodules. The lungs were inflated with an aqueous suspension of India ink injected via the trachea, washed in running water and fixed in Fekete's solution. Tumour nodules were easily visible against the normal lung surface.
Initially, challenge inocula were given at a low cell dose and if this failed to produce tumours the experimental rats were rechallenged with a higher cell dose about 6 weeks later. This was repeated until challenge tumours grew progressively in immunized rats, a new untreated control group being used each time. This procedure was adopted to prevent possible overwhelming of weak immune responses by large initial challenge inocula. In some experiments sham-operated controls were used in addition to untreated response to Sp7 at early generations has been confirmed independently (C. R. Barker, unpublished (Table V) . Experiments were also carried out in which immune responses were evaluated following suppression of tumour growth by contact with the bacterial adjuvants BCG and C. parvum. These agents have previously been known to be capable of suppressing the growth of many types of tumour cells placed in contact with them Milas & Scott, 1978) . In pilot experiments, Sp7 proved to be difficult to control with admixed BCG or C. parvum and insufficient numbers of tumour-free rats were obtained to evaluate tumour-immune responses by viable-cell challenges. However, Sp24 and Sp4l could be suppressed by both agents, and results of rechallenging the animals with the immunizing tumours are shown in Table VI . With Sp24, immunization with tumour cells and BCG produced no immunity to further challenge, but after treatment with cells suppressed by contact with C. parvum challenge with 104 Sp24 cells failed to produce tumours. This effect, however, was not statistically significant (P > 0.05). Immunity could not be demonstrated with Sp41 even though the latter appeared to be more antigenic than Sp24 in previous tests (Tables I and II) . A limited number of cross-challenge tests were performed in order to determine whether induced immunity to the spontaneously-arising sarcomas was due to individual or cross-reacting antigens (Table VII) . Animals immunized with irradiated Sp7 cells were challenged with either Sp7, Sp24 or Sp4l cells, using comparable cell doses. These animals rejected 105 Sp7 cells, but succumbed to a similar dose of Sp4l cells or 4 x 104 Sp24 cells. Conversely, rats similarly immunized with irradiated Sp24 or Sp4l cells were not able to reject 2 x 104 Sp7 cells. These results indicate that immunity to Sp7 was induced by an individually specific antigen rather than a shared antigeni.
DISCUSSION
The results of our immunogenicity tests clearly demonstrate that some spontaneously arising rat tumours possess tumour-associated antigens capable of inducing a tumour rejection response in syngeneic hosts. This has previously been observed with a number of different spontaneous tumours in the same rat strain (Baldwin, 1966; Baldwin & Embleton, 1969 6/6 6/6 6/6 6/6 was intensified to produce large numbers of rats, and this, combined with more vigilant examination of breeders, led to a higher rate of accumulation of spontaneous tumours. These were the subject of a larger immunogenicity-screening programme with essentially negative findings (Middle & Embleton, in preparation) . This, together with the observation that a relatively small proportion of rat mammary tumours were antigenic in previous work (Baldwin & Embleton, 1969) , leads us to conclude that most spontaneous rat tumours are not detectably immunogenic in syngeneic hosts, but there are notable exceptions. In this study, for example, sarcomas Sp7 and Sp4l were characterized by weak, but detectable, tumour-associated antigens. In the case of Sp7 this antigen was individually specific and not shared by Sarcomas Sp4l or Sp24. This confirms observations of Hammond et al. (1967) , who showed that antigens associated with spontaneous mouse sarcomas or myoepitheliomas were tumour-specific, and Baldwin & Embleton (1969) , who demonstrated the unique antigenicity of 3 spontaneous rat mammary carcinomas. One possible explanation for the negative immunogenicity of 2 other sarcomas in our study is that the techniques used for their demonstration were inadequate. However, this is probably not the case, because several different methods of immunization and challenge were evaluated. Our standard methods of immunization by excision of tumour grafts or implantation of 150 Gy irradiated tissue followed by s.c. challenge at growth threshold levels (Tables I and II) proved to be optimum for the demonstration of antigens on the positive tumours. Antigens other than transplantation antigens can sometimes be detected on spontaneous tumours by in vitro tests (Baldwin & Embleton, 1974) but these are of doubtful significance with regard to tumour immunity. Another reason may be that antigens on these tumours preferentially induce suppressor responses rather than efficient effector responses. This possibility has been explored with some of the apparently non-immunogenic tumours and no evidence of suppressor responses could be found (Middle et al., unpublished) . It therefore seems most likely that the poor immunogenicity of most spontaneous tumours reflects a lack of tumour-associated rejection antigens or a deficiency in their expression at the cell surface.
This has led to criticism of the value of immunotherapy against tumours (Hewitt, 1978 (Hewitt, , 1979 . showed that BCG could suppress the growth of some spontaneous rat tumours if they were injected s.c. in admixture (contact suppression) but specific active immunotherapy of tumour at a distant site was unsuccessful, except in the case of a single mammary carcinoma (Sp4) which was previously shown to be fairly strongly immunogenic (Baldwin & Embleton, 1969) . Similar results were obtained in later experiments using C. parvum instead of BCG (Willmott et al., 1979) . In the present studies immunity to rechallenge was evaluated in rats the tumours of which were suppressed by contact with BCG or C. parvum, and it was found that in most cases they failed to reject the challenge inoculum. Contact suppression probably involves local host mechanisms (Bartlett et al., 1972; Moore et al., 1975; but therapy of tumour at a distant site probably includes a component of systemic anti-tumour immunity (Greager & Baldwin, 1978) , so these results are not encouraging with regard to immunotherapy of distant tumour deposits. Analogies have been drawn between spontaneous animal tumour models and human tumours (Hewitt, 1978 (Hewitt, , 1979 and in this context it is apparent that immunotherapy of human tumours with bacterial adjuvants has not lived up to early expectations (Baldwin, 1979) .
The relevance of spontaneous animal tumours to human cancer cannot be stated with certainty, but there is support for the belief that they are more closely comparable with the human disease than are most artificially induced models. As pointed out by Hewitt et al. (1976) , it is thus important to exercise caution in the extrapolation of data obtained with highly immunogenic models. Since detectable levels of immunity can be induced against a proportion of spontaneous tumours, however, it is equally important not to adopt too negative an attitude, but to continue to exploit new approaches which stand a chance of increasing host resistance against them.
